Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus/Tacrolimus for GVHD Prophylaxis
NCT01488253Phase 2Terminated
- Sponsor
- Korean Society of Blood and Marrow Transplantation
- Start
- Jan 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in graft-versus-host disease (GVHD), sponsored by Korean Society of Blood and Marrow Transplantation. Started Jan 2012; status: terminated.
02
Drugs
sirolimus
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT01488253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01488253.